Combination of preS deletions and A1762T/G1764A mutations in HBV subgenotype C2 increases the risk of developing HCC

Intervirology

Volumn 55, Issue 4, 2012, Pages 296-302

  Lee, Myoung Ha ^a   Kim, Do Young ^a,c   Kim, Ja Kyung ^a,c   Chang, Hye Young ^c   Kang, Se Hun ^a   Ryu, Han Jak ^a   Ju, Hye Lim ^a   Kim, Seung Up ^a,c   Lee, Jung Min ^a,c   Park, Jun Yong ^a,c   Han, Kwang Hyub ^a,b,c   Chon, Chae Yoon ^a,c   Ahn, Sang Hoon ^a,b,c  

^a Yonsei University College of Medicine   (South Korea)

^b Brain Korea 21 Project for Medical Science   (South Korea)

^c Liver Cirrhosis Clinical Research Center   (South Korea)

Author keywords

A1762T G1764A mutations; G1896A mutation; Hepatitis B virus; Hepatocellular carcinoma; preS deletions

Indexed keywords

HEPATITIS B(E) ANTIGEN;

ADULT; ARTICLE; CANCER RISK; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE DELETION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRES1 GENE; PRES2 GENE; PRIORITY JOURNAL; SOUTH KOREA; VIRUS GENE; VIRUS ISOLATION; VIRUS MUTATION; VIRUS TYPING;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; GENOTYPE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN PRECURSORS; REPUBLIC OF KOREA; RISK ASSESSMENT; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; VIRULENCE FACTORS;

HEPATITIS B VIRUS;

EID: 84861188808     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000329941     Document Type: Article

References (35)

1. Parkin DM: International variation. Oncogene 2004; 23: 6329-6340. (Pubitemid 39272833)
2. Beasley RP, Hwang LY, Lin CC, Chien CS: Hepatocellular carcinoma and hepatitis b virus: a prospective study of 22,707 men in Taiwan. Lancet 1981;ii:1129-1133.
3. Yoon YJ, Chang HY, Ahn SH, Kim JK, Park YK, Kang DR, Park JY, Myoung SM, Kim do Y, Chon CY, Han KH: Mdm2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis b virus infection. Carcinogenesis 2008; 29: 1192-1196. (Pubitemid 351964880)
4. Kim BK, Park JY, Kim do Y, Kim JK, Kim KS, Choi JS, Moon BS, Han KH, Chon CY, Moon YM, Ahn SH: Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection. Liver Int 2008; 28: 393-401. (Pubitemid 351279588)
5. Chan HL, Sung JJ: Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis 2006; 26: 153-161. (Pubitemid 43668257)
6. Chen CH, Changchien CS, Lee CM, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN: Combined mutations in pre-S/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study. J Infect Dis 2008; 198: 1634-1642.
7. Kim JK, Chang HY, Lee JM, Baatarkhuu O, Yoon YJ, Park JY, Kim do Y, Han KH, Chon CY, Ahn SH: Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma. J Med Virol 2009; 81: 1002-1008.
8. Preikschat P, Gunther S, Reinhold S, Will H, Budde K, Neumayer HH, Kruger DH, Meisel H: Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients. Hepatology 2002; 35: 466-477. (Pubitemid 34106390)
9. Choi MS, Kim DY, Lee DH, Lee JH, Koh KC, Paik SW, Rhee JC, Yoo BC: Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J Viral Hepat 2007; 14: 161-168.
10. Kay A, Zoulim F: Hepatitis B virus genetic variability and evolution. Virus Res 2007; 127: 164-176. (Pubitemid 47064411)
11. Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS: Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology 2007; 133: 1466-1474.
12. Kao JH, Chen PJ, Lai MY, Chen DS: Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 2003; 124: 327-334.
13. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC: Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; 2: 588-591. (Pubitemid 19216208)
14. Tong MJ, Blatt LM, Kao JH, Cheng JT, Corey WG: Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma. World J Gastroenterol 2006; 12: 6620-6626. (Pubitemid 44794938)
15. Yu H, Yuan Q, Ge SX, Wang HY, Zhang YL, Chen QR, Zhang J, Chen PJ, Xia NS: Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype 'I'. PLoS One;5:e9297.
16. Chan HL, Hui AY, Wong ML, Tse AM, Hung LC, Wong VW, Sung JJ: Genotype c hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 2004; 53: 1494-1498. (Pubitemid 39265273)
17. Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G: Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst 2009; 101: 1066-1082.
18. Shinkai N, Tanaka Y, Ito K, Mukaide M, Hasegawa I, Asahina Y, Izumi N, Yatsuhashi H, Orito E, Joh T, Mizokami M: Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2. J Clin Microbiol 2007; 45: 3191-3197. (Pubitemid 47585639)
19. Mizokami M, Nakano T, Orito E, Tanaka Y, Sakugawa H, Mukaide M, Robertson BH: Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns. FEBS Lett 1999; 450: 66-71. (Pubitemid 29206714)
20. Azam F, Koulaouzidis A: Hepatitis B virus and hepatocarcinogenesis. Ann Hepatol 2008; 7: 125-129. (Pubitemid 351845522)
21. Pang R, Tse E, Poon RT: Molecular pathways in hepatocellular carcinoma. Cancer Lett 2006; 240: 157-169. (Pubitemid 44093818)
22. Kurbanov F, Tanaka Y, Mizokami M: Geographical and genetic diversity of the human hepatitis B virus. Hepatol Res 2010; 40: 14-30.
23. Lee JM, Ahn SH, Chang HY, Shin JE, Kim DY, Sim MK, Hong SP, Chung HJ, Kim SO, Han KH, Chon CY, Moon YM: Reappraisal of HBV genotypes and clinical significance in Koreans using MALDI-TOF mass spectrometry. Korean J Hepatol 2004; 10: 260-270.
24. Ahn SH, Yuen L, Han KH, Littlejohn M, Chang HY, Damerow H, Ayres A, Heo J, Locarnini S, Revill PA: Molecular and clinical characteristics of hepatitis B virus in Korea. J Med Virol 2010; 82: 1126-1134.
25. Ahn SH, Yuen L, Revill P: Clarification required for the definition of hepatitis B virus subgenotypes C1 and C2. Intervirology 2009; 52: 321-322.
26. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS: High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 2006; 130: 1153-1168.
27. Neurath AR, Kent SB, Strick N, Parker K: Delineation of contiguous determinants essential for biological functions of the pre-S sequence of the hepatitis B virus envelope protein: its antigenicity, immunogenicity and cell-receptor recognition. Ann Inst Pasteur Virol 1988; 139: 13-38. (Pubitemid 18079637)
28. Guo X, Jin Y, Qian G, Tu H: Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qigong, China. J Hepatol 2008; 49: 718-725.
29. Murakami S: Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol 2001; 36: 651-660. (Pubitemid 33040937)
30. Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M: Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991; 324: 1699-1704.
31. Tong MJ, Blatt LM, Kao JH, Cheng JT, Corey WG: Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma. World J Gastroenterol 2006; 12: 6620-6626. (Pubitemid 44794938)
32. Harrison TJ: Hepatitis B virus: molecular virology and common mutants. Semin Liver Dis 2006; 26: 87-96. (Pubitemid 43668251)
33. Chou YC, Yu MW, Wu CF, Yang SY, Lin CL, Liu CJ, Shih WL, Chen PJ, Liaw YF, Chen CJ: Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Gut 2008; 57: 91-97.
34. Tanaka Y, Mukaide M, Orito E, Yuen MF, Ito K, Kurbanov F, Sugauchi F, Asahina Y, Izumi N, Kato M, Lai CL, Ueda R, Mizokami M: Specific mutations in enhancer ii/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. J Hepatol 2006; 45: 646-653. (Pubitemid 44466666)
35. Yuen MF, Tanaka Y, Shinkai N, Poon RT, But DY, Fong DY, Fung J, Wong DK, Yuen JC, Mizokami M, Lai CL: Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. Gut 2008; 57: 98-102.